Your browser doesn't support javascript.
loading
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.
Reckamp, Karen L; Koczywas, Marianna; Cristea, Mihaela C; Dowell, Jonathan E; Wang, He-Jing; Gardner, Brian K; Milne, Ginger L; Figlin, Robert A; Fishbein, Michael C; Elashoff, Robert M; Dubinett, Steven M.
Afiliação
  • Reckamp KL; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Koczywas M; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Cristea MC; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Dowell JE; Department of Medicine, Veterans Affairs North Texas Healthcare System, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Wang HJ; Department of Biomathematics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Gardner BK; Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Milne GL; Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee.
  • Figlin RA; Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Fishbein MC; Department of Pathology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Elashoff RM; Department of Biomathematics, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
  • Dubinett SM; Departments of Medicine and Pathology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California.
Cancer ; 121(18): 3298-306, 2015 Sep 15.
Article em En | MEDLINE | ID: mdl-26033830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article